FindTrial
Sign In

comparison of two local delivery drug in gums of patients suffering from pyorrhoea disease

Comparative Evaluation Of Curcumin Chip With Chlorhexidine Chip as a Local Drug Delivery in Management of Chronic Periodontitis-A randomized Control Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048514
Enrollment
29
Registered
2022-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Curcumin chip: 5%Curcumin has proven properties such as anti-inflammatory, antioxidant, antimicrobial, immunostimulant, antiseptic, antimutagenic, and also accelerates wound healing.Thi

Sponsors

DrAayushi Shah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with Stage II chronic Periodontitis1 Patients with Age Group between 18-65 years. Teeth having pocket probing depth (PPD) =4mm

Exclusion criteria

Exclusion criteria: 1. Pregnant And Lactating women. 2. Patient with history of any kind of periodontal therapy within 6 months. 3. Medically compromised patients. 4. Teeth showing any endoperio lesions, restoration 5. Smokers and tobacco chewers. 6. Allergic to chlorhexidine. 7. Patients undergoing Orthodontic treatment. 8. Patients who are not willing for the treatment.

Design outcomes

Primary

MeasureTime frame
Plaque Index, bleedinglIndex, Probing Depth, Relative Attachment Level. Timepoint: baseline, 30 days—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactDrNeeraj deshpande

K.M.shah dental college and hospital

drneeraj78@gmail.com7600918500

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026